Blue Trust Inc’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Blue Trust Inc’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-278	Closed	-$1K	–	2800
2023 Q4	$1K	Buy	+278	New	+$848	﹤0.01%	2457

Blue Trust Inc's THRX Position: Q1 2024 in Review

Blue Trust Inc sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 278 shares — an estimated $1K sold.

Blue Trust Inc first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $1K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Blue Trust Inc reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Blue Trust Inc sold 278 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $1K.
Blue Trust Inc first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Blue Trust Inc's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Blue Trust Inc's 13F filing for Q1 2024, filed 1 May 2024.